Carregant...
Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era
BACKGROUND: iPLEDGE is the mandatory regulatory program for isotretinoin in the United States, aimed to prevent isotretinoin-related teratogenicity. However, little is known about potential unintended impact of the program, including delay in isotretinoin initiation, course interruption, and prematu...
Guardat en:
| Publicat a: | PLoS One |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6435230/ https://ncbi.nlm.nih.gov/pubmed/30913210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0210445 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|